Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of the COVID-19 pandemic on tuberculosis laboratory services in Europe
Vladyslav Nikolayevskyy, Yen Holicka, Dick van Soolingen, et al.
European Respiratory Journal (2020) Vol. 57, Iss. 1, pp. 2003890-2003890
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

The European Union One Health 2021 Zoonoses Report

EFSA Journal (2022) Vol. 20, Iss. 12
Open Access | Times Cited: 560
Impact of the COVID-19 pandemic on tuberculosis management in Spain
María Luisa Aznar, Juan Espinosa‐Pereiro, Núria Saborit, et al.
International Journal of Infectious Diseases (2021) Vol. 108, pp. 300-305
Open Access | Times Cited: 63
The COVID-19 and TB syndemic: the way forward
Anete Trajman, Irina Felker, Layana Costa Alves, et al.
The International Journal of Tuberculosis and Lung Disease (2022) Vol. 26, Iss. 8, pp. 710-719
Open Access | Times Cited: 53
Changing Epidemiology of Respiratory Tract Infection during COVID-19 Pandemic
Hung-Jen Tang, Chih‐Cheng Lai, Chien‐Ming Chao
Antibiotics (2022) Vol. 11, Iss. 3, pp. 315-315
Open Access | Times Cited: 40
Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis
Michael Reid, Yvan Jean Patrick Agbassi, Nimalan Arinaminpathy, et al.
The Lancet (2023) Vol. 402, Iss. 10411, pp. 1473-1498
Closed Access | Times Cited: 30
Impact of COVID-19 pandemic and anti-pandemic measures on tuberculosis, viral hepatitis, HIV/AIDS and malaria–A systematic review
Barbora Kessel, Torben Heinsohn, Jördis J. Ott, et al.
PLOS Global Public Health (2023) Vol. 3, Iss. 5, pp. e0001018-e0001018
Open Access | Times Cited: 22
Tuberculosis in an Aging World
Angélica M. Olmo-Fontánez, Joanne Turner
Pathogens (2022) Vol. 11, Iss. 10, pp. 1101-1101
Open Access | Times Cited: 33
Impact of COVID-19 Pandemic on Tuberculosis Preventive Services and Their Post-Pandemic Recovery Strategies: A Rapid Review of Literature
Yoolwon Jeong, Jinsoo Min
Journal of Korean Medical Science (2023) Vol. 38, Iss. 5
Open Access | Times Cited: 18
Incidence, severity and treatment outcome of tuberculosis in the era of the COVID-19 pandemic, France, 2018–2023
Jean‐Paul Guthmann, J. Robert, Delphine Viriot, et al.
Deleted Journal (2025) Vol. 73, Iss. 1, pp. 202795-202795
Closed Access
Influência da cobertura de atenção básica e das visitas domiciliares na detecção de casos de tuberculose na cidade do Rio de Janeiro, Brasil, 2014-2022
Fernanda Lopes, Fernanda Carvalho de Queiroz Mello, C Barbosa, et al.
Cadernos de Saúde Pública (2025) Vol. 41, Iss. 2
Open Access
Increase in tuberculosis among children and young adolescents, European Union/European Economic Area, 2015 to 2023
Veronica Cristea, Csaba Ködmön, Joana Gomes Dias, et al.
Eurosurveillance (2025) Vol. 30, Iss. 11
Open Access
Long-term impact of the COVID-19 pandemic on health services utilization in China: A nationwide longitudinal study
Jue Liu, Xiaohui Zhai, Wenxin Yan, et al.
Global Transitions (2023) Vol. 5, pp. 21-28
Open Access | Times Cited: 11
The effect of Covid-19 pandemic on healthcare utilization in public vs private centers in Iran: a multiple group interrupted time-series analysis
Zohreh Rezaei, Farhad Hosseinzadeh Lotfı, Mohsen Bayati, et al.
BMC Health Services Research (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10
The global impact of COVID-19 on tuberculosis: A thematic scoping review, 2020–2023
Michael H. Marco, Sevim Ahmedov, Kenneth G. Castro
PLOS Global Public Health (2024) Vol. 4, Iss. 7, pp. e0003043-e0003043
Open Access | Times Cited: 3
Job Crafting and Nurses' Presenteeism: The Effects of Job Embeddedness and Job Irreplaceability
Taotao Liu, Wei Wang, Geyan Shan, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 18
Retrospective Cohort Study of Effects of the COVID-19 Pandemic on Tuberculosis Notifications, Vietnam, 2020
Tasnim Hasan, Viet Nhung Nguyen, Hoa Binh Nguyen, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 3, pp. 684-692
Open Access | Times Cited: 15
Effect of COVID-19 pandemic on incidence of mycobacterial diseases among suspected tuberculosis pulmonary patients in Tehran, Iran
Jafar Aghajani, Poopak Farnia, Parissa Farnia, et al.
International Journal of Mycobacteriology (2022) Vol. 11, Iss. 4, pp. 415-422
Open Access | Times Cited: 12
Tuberculosis in the European Region
Jessica Mencarini, Michele Spinicci, Lorenzo Zammarchi, et al.
Current Tropical Medicine Reports (2023) Vol. 10, Iss. 3, pp. 88-93
Open Access | Times Cited: 7
The Global Impact of COVID-19 on Tuberculosis: A Thematic Scoping Review, 2020-2023
Michael H. Marco, Sevim Ahmedov, Kenneth G. Castro
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Impact of the COVID-19 pandemic on tuberculosis national reference laboratory services in the WHO European Region, March to November 2020
Florian P. Maurer, Natalia Shubladze, Gulmira Kalmambetova, et al.
Eurosurveillance (2021) Vol. 26, Iss. 24
Open Access | Times Cited: 15
The aftermath of COVID-19 pandemic on the diagnosis of TB at a tertiary care hospital in India
Druti Hazra, Kiran Chawla, Vishnu Prasad Shenoy, et al.
Journal of Infection and Public Health (2021) Vol. 14, Iss. 8, pp. 1095-1098
Open Access | Times Cited: 13
Exploring the perspectives of members of international tuberculosis control and research networks on the impact of COVID-19 on tuberculosis services: a cross sectional survey
Oluwatosin Nkereuwem, Esin Nkereuwem, Arnauld Fiogbe, et al.
BMC Health Services Research (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Using a systematic approach to strategic innovation in laboratory medicine to bring about change
Deirdre L. Church, Christopher Naugler
Critical Reviews in Clinical Laboratory Sciences (2022) Vol. 59, Iss. 3, pp. 178-202
Closed Access | Times Cited: 8
Ending tuberculosis in Europe - resetting the course in the post-COVID-19 era
A Ammon, Hans Kluge
Eurosurveillance (2023) Vol. 28, Iss. 12
Open Access | Times Cited: 4
SMA-TB: study protocol for the phase 2b randomized double-blind, placebo-controlled trial to estimate the potential efficacy and safety of two repurposed drugs, acetylsalicylic acid and ibuprofen, for use as adjunct therapy added to, and compared with, the standard WHO recommended TB regimen
Lilibeth Arias, Kennedy Otwombe, Ziyaad Waja, et al.
Trials (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top